Oripavine: Difference between revisions
CSV import |
CSV import |
||
| Line 23: | Line 23: | ||
{{stub}} | {{stub}} | ||
== Oripavine == | |||
<gallery> | |||
File:Bridged_oripavine_general.svg|Diagram of bridged oripavine structure | |||
File:Morphine_biosynthesis.png|Pathway of morphine biosynthesis | |||
File:Caviar,_Bob_Bob_Ricard,_Soho,_London.jpg|Caviar served at Bob Bob Ricard, Soho, London | |||
</gallery> | |||
Latest revision as of 00:41, 18 February 2025
Oripavine is a morphinan alkaloid that is used in the manufacture of pharmaceuticals. It is a natural product found in the Papaveraceae family of plants, including the opium poppy (Papaver somniferum) and the Iranian poppy (Papaver bracteatum).
Chemistry[edit]
Oripavine is structurally related to morphine and codeine, but has a different molecular structure. It is a morphinan alkaloid, which means it contains a morphinan skeleton with an additional hydroxyl group at the 6 position. This hydroxyl group is crucial for the bioactivity of oripavine.
Pharmacology[edit]
Oripavine has analgesic properties similar to those of other opioids. It acts as an agonist at the mu-opioid receptor, which is the primary site of action for the most commonly used opioids. Oripavine also has a high affinity for the delta-opioid receptor and the kappa-opioid receptor, although its effects at these sites are less well understood.
Medical uses[edit]
Oripavine is used in the manufacture of a number of pharmaceuticals. It is a precursor in the synthesis of several semi-synthetic opioids, including buprenorphine, etorphine, and diprenorphine. These drugs are used for the treatment of pain, opioid dependence, and in veterinary medicine.
Legal status[edit]
In many countries, oripavine is a controlled substance due to its potential for abuse and addiction. In the United States, it is classified as a Schedule II controlled substance under the Controlled Substances Act.


